Scarica l'app Stockscreener
136.99
4.03%
5.31
Dopo l'orario di chiusura:
136.99
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Illumina Inc Borsa (ILMN) Ultime notizie
Trailblazing study shows early CGP leads to better precision treatments - Illumina
Connor Clark & Lunn Investment Management Ltd. Buys 114,466 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Myriad Genetics Announces Incorporation of its Proprietary - GlobeNewswire
Myriad Genetics Expands Illumina Partnership, Integrates Key Cancer Testing Technology | MYGN Stock News - StockTitan
(ILMN) Trading Report - Stock Traders Daily
Illumina's Moat in Sequencing Remains Narrow - Morningstar
Illumina gear up to expand TruSight Oncology portfolio - Yahoo Finance
ILMN Stock Set to Gain From Expansion of TruSight Oncology Portfolio - Yahoo Finance
Gene Panel Market: Rapid Growth with Strong Future CAGR and Top - openPR
Victory Capital Management Inc. Has $16.48 Million Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Biological Multiplex Assays Market to Witness Significant - openPR
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
U.S. STOCKS Merck, Microstrategy, Illumina - XM
Illumina announces expansion of TruSight Oncology portfolio - PR Newswire
LMR Partners LLP Acquires Shares of 21,285 Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
RNA Sequencing Market Expected to Experience Positive Growth - openPR
NGS Based RNA Sequencing Market 2024 Analysis of Key Trends, - openPR
Digital Genome Market May See a Big Move | Illumina, GE Healthcare, Inscripta - openPR
How two systems integration scientists ensure a smooth workflow on MiSeq i100 - Illumina
Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now? - Yahoo Finance
Illumina, Inc. (NASDAQ:ILMN) Shares Sold by Mutual of America Capital Management LLC - MarketBeat
CIBC Asset Management Inc Reduces Stock Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
10 Best Immunotherapy Stocks to Buy Now - Insider Monkey
NGS & Microarray Training - Illumina
Impax Asset Management Group plc Increases Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
North America Bioinformatics Market Statistical Forecast - openPR
ING Groep NV Raises Stake in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Plato Investment Management Ltd Raises Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Oppenheimer & Co. Inc. Has $5.33 Million Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
DNA Test Kits Market Future Business Opportunities 2024-2031 | - openPR
Instrument Services - Illumina
Illumina Inc. stock outperforms competitors despite losses on the day - MarketWatch
12,000 Shares in Illumina, Inc. (NASDAQ:ILMN) Purchased by Freemont Management S.A. - MarketBeat
10,563 Shares in Illumina, Inc. (NASDAQ:ILMN) Bought by Entropy Technologies LP - MarketBeat
Illumina's SWOT analysis: ngs leader faces competition, aims for growth - Investing.com
Biochips Market Is Booming Worldwide 2024-2031 | Illumina, - openPR
Illumina's SWOT analysis: ngs leader faces competition, aims for growth By Investing.com - Investing.com UK
Urban Illumina 2024 at MDI Gurgaon Illuminates Insights, Entertainment, and Engagement through Disguised Market Research - Passionate In Marketing
Single-cell RNA analysis finds possible genetic drivers of bone cancer - Illumina
Mengis Capital Management Inc. Purchases New Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Consumer Genomics Industry Next Big Thing | Major Giants- Veritas, Illumina, Xcode Life - openPR
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
OVERSEA CHINESE BANKING Corp Ltd Sells 39,734 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina (NASDAQ:ILMN) Receives Equal Weight Rating from Morgan Stanley - MarketBeat
Baillie Gifford & Co. Lowers Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Bioinformatics Services Market: Size, Share, Trends, - openPR
Los Angeles Capital Management LLC Boosts Stock Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina, Inc. (ILMN): Unlocking Growth Potential in Genetic Testing and Robotics - Insider Monkey
Illumina Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
WCM Investment Management LLC Has $424.48 Million Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Neuroscience Market Projected to Reach USD 50.2 Billion by 2032, Growing at a 4.0% CAGR – S&S Insider - GlobeNewswire Inc.
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Piper Sandler Issues Pessimistic Forecast for Illumina (NASDAQ:ILMN) Stock Price - MarketBeat
Biological Multiplex Assays Market Report Analysis - openPR
Ownership Capital B.V. Sells 181,945 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Principal Financial Group Inc. Lowers Stock Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Trend Tracker for (ILMN) - Stock Traders Daily
Carmel Capital Partners LLC Decreases Stock Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Kornitzer Capital Management Inc. KS Has $2.75 Million Stock Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Here’s Why You Should Invest in Illumina (ILMN) - Insider Monkey
Illumina signs MoU with PHASE to Advance Oncology Testing in the Greater Bay Area and Contribute to the ''Healthy China'' - PR Newswire
AIA Group Ltd Increases Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
NHS Wales partners with Illumina on genomics drive - pharmaphorum
Interpreting Illumina (ILMN) International Revenue Trends - Yahoo Finance
Q4 Earnings Estimate for Illumina Issued By Leerink Partnrs - MarketBeat
Radnor Capital Management LLC Invests $910,000 in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
0.88%
0.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):